Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21.
Assays of the activity of chromosome 21 determined superoxide dismutase-1 (SOD-1) in lymphocytes and polymorphonuclear granulocytes have demonstrated 38% and 40% increases, respectively, in cells from individuals with trisomy 21. Similarly, SOD-1 activity in trisomic fibroblasts is increased by 81%, while cells monosomic for chromosome 21 have only 60% of normal activity. Taken together with the data on SOD-1 activities in trisomic erythrocytes and platelets, the present results firmly confirm the existence of a true dosage effect for this enzyme in cells aneuploid for chromosome 21. However, the results of assays of the activity of glutathione peroxidase in trisomic fibroblasts did not confirm the possibility previously reported of a chromosome 21 related dosage effect for this enzyme.
D002460:Cell Line; D002904:Chromosomes, Human, 21-22 and Y; D004314:Down Syndrome / Q000201:enzymology* / Q000235:genetics; D005347:Fibroblasts / Q000201:enzymology; D005979:Glutathione Peroxidase / Q000378:metabolism; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology; D009504:Neutrophils / Q000201:enzymology; D013482:Superoxide Dismutase / Q000235:genetics* / Q000378:metabolism; D014314:Trisomy
D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase